| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Departments of Research and of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland; and 2 Department of Internal Medicine, University Hopital Düsseldorf, 40225 Düsseldorf, Germany
To investigate the effect of acute changes of extracellular osmolality on whole body protein and glucose metabolism, we studied 10 male subjects during three conditions: hyperosmolality was induced by fluid restriction and intravenous infusion of hypertonic NaCl [2-5%; (wt/vol)] during 17 h; hypoosmolality was produced by intravenous administration of desmopressin, liberal water drinking, and infusion of hypotonic saline (0.4%); and the isoosmolality study consisted of ad libitum oral water intake by the subjects. Leucine flux ([1-13C]leucine infusion technique), a parameter of whole body protein breakdown, decreased during the hypoosmolality study (P < 0.02 vs. isoosmolality). The leucine oxidation rate decreased during the hypoosmolality study (P < 0.005 vs. isoosmolality). Metabolic clearance rate of glucose during hyperinsulinemic-euglycemic clamping increased less during the hypoosmolality study than during the isoosmolality study (P < 0.04). Plasma insulin decreased, and plasma nonesterified fatty acids, glycerol, and ketone body concentrations and lipid oxidation increased during the hypoosmolality study. It is concluded that acute alterations of plasma osmolality influence whole body protein, glucose, and lipid metabolism; hypoosmolality results in protein sparing associated with increased lipolysis and lipid oxidation and impaired insulin sensitivity.
dehydration; nonesterified fatty acids; protein turnover; lipolysis; stable isotopes
This article has been cited by other articles:
|
|
 |
|
  A. Safdar, N. J. Yardley, R. Snow, S. Melov, and M. A. Tarnopolsky Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation Physiol Genomics, January 17, 2008; 32(2): 219 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Antolic, R. Harrison, C. Farlinger, N. M. Cermak, S. J. Peters, P. LeBlanc, and B. D. Roy Effect of extracellular osmolality on cell volume and resting metabolism in mammalian skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1994 - R2000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Menezes, C. Sobreira, L. Neder, A. L. Rodrigues-Junior, and J. A. Baddini Martinez Creatine supplementation attenuates corticosteroid-induced muscle wasting and impairment of exercise performance in rats J Appl Physiol, February 1, 2007; 102(2): 698 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Paddon-Jones, E. Borsheim, and R. R. Wolfe Potential Ergogenic Effects of Arginine and Creatine Supplementation J. Nutr., October 1, 2004; 134(10): 2888S - 2894S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Parise, S. Mihic, D. MacLennan, K. E. Yarasheski, and M. A. Tarnopolsky Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis J Appl Physiol, September 1, 2001; 91(3): 1041 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Haussinger, D. Graf, and O. H. Weiergraber Glutamine and Cell Signaling in Liver J. Nutr., September 1, 2001; 131(9): 2509S - 2514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Persky and G. A. Brazeau Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate Pharmacol. Rev., June 1, 2001; 53(2): 161 - 176. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
